Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Pathogen Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Pathogen Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-08-08
Pages: 136 Pages
Report ld: 4917513
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pathogen Testing Market Size(US$)
CAGR 2025-2031
7.8%
Market Size,2031
USD 9,467
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 6,033 million
Market Forecast in 2031(Value)
US$ 9,467 million
CAGR
7.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pathogen Testing market is projected to grow from US$ 5637 million in 2024 to US$ 9467 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Global Pathogen Testing includes SGS SA, Eurofins Scientific, Institut Mérieux, etc. Global top three companies hold a share over 40%. Europe is the largest market, with a share about 26%, followed by North America and China with the share about 21% and 17%.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pathogen Testing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- SGS SA
- Eurofins Scientific
- Institut Mérieux
- ALS Limited
- Charles River
- Intertek Group
- Symbio Laboratories
- TUV Nord
- FoodChain ID Group
- AsureQuality
- Microbac Laboratories
- Guangdong IQTC
- IFP Institut für Produktqualität GmbH
- Vimta Labs
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- PCR
- LAMP
Segment by Application
- Food Industry
- Laboratory
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Pathogen Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Pathogen Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pathogen Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 LAMP
1.3 Market Segmentation by Application
1.3.1 Global Pathogen Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Food Industry
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pathogen Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Pathogen Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pathogen Testing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pathogen Testing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 PCR Market Size by Players
3.3.2 LAMP Market Size by Players
3.4 Global Pathogen Testing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pathogen Testing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pathogen Testing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pathogen Testing Market Size by Type (2020-2031)
6.4 North America Pathogen Testing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pathogen Testing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pathogen Testing Market Size by Type (2020-2031)
7.4 Europe Pathogen Testing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pathogen Testing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pathogen Testing Market Size by Type (2020-2031)
8.4 Asia-Pacific Pathogen Testing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pathogen Testing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pathogen Testing Market Size by Type (2020-2031)
9.4 Central and South America Pathogen Testing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pathogen Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pathogen Testing Market Size by Type (2020-2031)
10.4 Middle East and Africa Pathogen Testing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pathogen Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 SGS SA
11.1.1 SGS SA Corporation Information
11.1.2 SGS SA Business Overview
11.1.3 SGS SA Pathogen Testing Product Features and Attributes
11.1.4 SGS SA Pathogen Testing Revenue and Gross Margin (2020-2025)
11.1.5 SGS SA Pathogen Testing Revenue by Product in 2024
11.1.6 SGS SA Pathogen Testing Revenue by Application in 2024
11.1.7 SGS SA Pathogen Testing Revenue by Geographic Area in 2024
11.1.8 SGS SA Pathogen Testing SWOT Analysis
11.1.9 SGS SA Recent Developments
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Corporation Information
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Pathogen Testing Product Features and Attributes
11.2.4 Eurofins Scientific Pathogen Testing Revenue and Gross Margin (2020-2025)
11.2.5 Eurofins Scientific Pathogen Testing Revenue by Product in 2024
11.2.6 Eurofins Scientific Pathogen Testing Revenue by Application in 2024
11.2.7 Eurofins Scientific Pathogen Testing Revenue by Geographic Area in 2024
11.2.8 Eurofins Scientific Pathogen Testing SWOT Analysis
11.2.9 Eurofins Scientific Recent Developments
11.3 Institut Mérieux
11.3.1 Institut Mérieux Corporation Information
11.3.2 Institut Mérieux Business Overview
11.3.3 Institut Mérieux Pathogen Testing Product Features and Attributes
11.3.4 Institut Mérieux Pathogen Testing Revenue and Gross Margin (2020-2025)
11.3.5 Institut Mérieux Pathogen Testing Revenue by Product in 2024
11.3.6 Institut Mérieux Pathogen Testing Revenue by Application in 2024
11.3.7 Institut Mérieux Pathogen Testing Revenue by Geographic Area in 2024
11.3.8 Institut Mérieux Pathogen Testing SWOT Analysis
11.3.9 Institut Mérieux Recent Developments
11.4 ALS Limited
11.4.1 ALS Limited Corporation Information
11.4.2 ALS Limited Business Overview
11.4.3 ALS Limited Pathogen Testing Product Features and Attributes
11.4.4 ALS Limited Pathogen Testing Revenue and Gross Margin (2020-2025)
11.4.5 ALS Limited Pathogen Testing Revenue by Product in 2024
11.4.6 ALS Limited Pathogen Testing Revenue by Application in 2024
11.4.7 ALS Limited Pathogen Testing Revenue by Geographic Area in 2024
11.4.8 ALS Limited Pathogen Testing SWOT Analysis
11.4.9 ALS Limited Recent Developments
11.5 Charles River
11.5.1 Charles River Corporation Information
11.5.2 Charles River Business Overview
11.5.3 Charles River Pathogen Testing Product Features and Attributes
11.5.4 Charles River Pathogen Testing Revenue and Gross Margin (2020-2025)
11.5.5 Charles River Pathogen Testing Revenue by Product in 2024
11.5.6 Charles River Pathogen Testing Revenue by Application in 2024
11.5.7 Charles River Pathogen Testing Revenue by Geographic Area in 2024
11.5.8 Charles River Pathogen Testing SWOT Analysis
11.5.9 Charles River Recent Developments
11.6 Intertek Group
11.6.1 Intertek Group Corporation Information
11.6.2 Intertek Group Business Overview
11.6.3 Intertek Group Pathogen Testing Product Features and Attributes
11.6.4 Intertek Group Pathogen Testing Revenue and Gross Margin (2020-2025)
11.6.5 Intertek Group Recent Developments
11.7 Symbio Laboratories
11.7.1 Symbio Laboratories Corporation Information
11.7.2 Symbio Laboratories Business Overview
11.7.3 Symbio Laboratories Pathogen Testing Product Features and Attributes
11.7.4 Symbio Laboratories Pathogen Testing Revenue and Gross Margin (2020-2025)
11.7.5 Symbio Laboratories Recent Developments
11.8 TUV Nord
11.8.1 TUV Nord Corporation Information
11.8.2 TUV Nord Business Overview
11.8.3 TUV Nord Pathogen Testing Product Features and Attributes
11.8.4 TUV Nord Pathogen Testing Revenue and Gross Margin (2020-2025)
11.8.5 TUV Nord Recent Developments
11.9 FoodChain ID Group
11.9.1 FoodChain ID Group Corporation Information
11.9.2 FoodChain ID Group Business Overview
11.9.3 FoodChain ID Group Pathogen Testing Product Features and Attributes
11.9.4 FoodChain ID Group Pathogen Testing Revenue and Gross Margin (2020-2025)
11.9.5 FoodChain ID Group Recent Developments
11.10 AsureQuality
11.10.1 AsureQuality Corporation Information
11.10.2 AsureQuality Business Overview
11.10.3 AsureQuality Pathogen Testing Product Features and Attributes
11.10.4 AsureQuality Pathogen Testing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Microbac Laboratories
11.11.1 Microbac Laboratories Corporation Information
11.11.2 Microbac Laboratories Business Overview
11.11.3 Microbac Laboratories Pathogen Testing Product Features and Attributes
11.11.4 Microbac Laboratories Pathogen Testing Revenue and Gross Margin (2020-2025)
11.11.5 Microbac Laboratories Recent Developments
11.12 Guangdong IQTC
11.12.1 Guangdong IQTC Corporation Information
11.12.2 Guangdong IQTC Business Overview
11.12.3 Guangdong IQTC Pathogen Testing Product Features and Attributes
11.12.4 Guangdong IQTC Pathogen Testing Revenue and Gross Margin (2020-2025)
11.12.5 Guangdong IQTC Recent Developments
11.13 IFP Institut für Produktqualität GmbH
11.13.1 IFP Institut für Produktqualität GmbH Corporation Information
11.13.2 IFP Institut für Produktqualität GmbH Business Overview
11.13.3 IFP Institut für Produktqualität GmbH Pathogen Testing Product Features and Attributes
11.13.4 IFP Institut für Produktqualität GmbH Pathogen Testing Revenue and Gross Margin (2020-2025)
11.13.5 IFP Institut für Produktqualität GmbH Recent Developments
11.14 Vimta Labs
11.14.1 Vimta Labs Corporation Information
11.14.2 Vimta Labs Business Overview
11.14.3 Vimta Labs Pathogen Testing Product Features and Attributes
11.14.4 Vimta Labs Pathogen Testing Revenue and Gross Margin (2020-2025)
11.14.5 Vimta Labs Recent Developments
12 Pathogen TestingIndustry Chain Analysis
12.1 Pathogen Testing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pathogen Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pathogen Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Pathogen Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pathogen Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pathogen Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pathogen Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pathogen Testing Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Pathogen Testing Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Pathogen Testing Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Pathogen Testing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pathogen Testing as of 2024)
Table 11. Global Pathogen Testing Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Pathogen Testing Companies Headquarters
Table 13. Global Pathogen Testing Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Pathogen Testing Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Pathogen Testing Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Pathogen Testing Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Pathogen Testing Revenue by Application (2026-2031) & (US$ Million)
Table 21. Pathogen Testing High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Pathogen Testing Growth Accelerators and Market Barriers
Table 25. North America Pathogen Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Pathogen Testing Growth Accelerators and Market Barriers
Table 27. Europe Pathogen Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Pathogen Testing Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Pathogen Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Pathogen Testing Investment Opportunities and Key Challenges
Table 31. Central and South America Pathogen Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Pathogen Testing Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Pathogen Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. SGS SA Corporation Information
Table 35. SGS SA Description and Major Businesses
Table 36. SGS SA Product Features and Attributes
Table 37. SGS SA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. SGS SA Revenue Proportion by Product in 2024
Table 39. SGS SA Revenue Proportion by Application in 2024
Table 40. SGS SA Revenue Proportion by Geographic Area in 2024
Table 41. SGS SA Pathogen Testing SWOT Analysis
Table 42. SGS SA Recent Developments
Table 43. Eurofins Scientific Corporation Information
Table 44. Eurofins Scientific Description and Major Businesses
Table 45. Eurofins Scientific Product Features and Attributes
Table 46. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Eurofins Scientific Revenue Proportion by Product in 2024
Table 48. Eurofins Scientific Revenue Proportion by Application in 2024
Table 49. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Eurofins Scientific Pathogen Testing SWOT Analysis
Table 51. Eurofins Scientific Recent Developments
Table 52. Institut Mérieux Corporation Information
Table 53. Institut Mérieux Description and Major Businesses
Table 54. Institut Mérieux Product Features and Attributes
Table 55. Institut Mérieux Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Institut Mérieux Revenue Proportion by Product in 2024
Table 57. Institut Mérieux Revenue Proportion by Application in 2024
Table 58. Institut Mérieux Revenue Proportion by Geographic Area in 2024
Table 59. Institut Mérieux Pathogen Testing SWOT Analysis
Table 60. Institut Mérieux Recent Developments
Table 61. ALS Limited Corporation Information
Table 62. ALS Limited Description and Major Businesses
Table 63. ALS Limited Product Features and Attributes
Table 64. ALS Limited Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. ALS Limited Revenue Proportion by Product in 2024
Table 66. ALS Limited Revenue Proportion by Application in 2024
Table 67. ALS Limited Revenue Proportion by Geographic Area in 2024
Table 68. ALS Limited Pathogen Testing SWOT Analysis
Table 69. ALS Limited Recent Developments
Table 70. Charles River Corporation Information
Table 71. Charles River Description and Major Businesses
Table 72. Charles River Product Features and Attributes
Table 73. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Charles River Revenue Proportion by Product in 2024
Table 75. Charles River Revenue Proportion by Application in 2024
Table 76. Charles River Revenue Proportion by Geographic Area in 2024
Table 77. Charles River Pathogen Testing SWOT Analysis
Table 78. Charles River Recent Developments
Table 79. Intertek Group Corporation Information
Table 80. Intertek Group Description and Major Businesses
Table 81. Intertek Group Product Features and Attributes
Table 82. Intertek Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Intertek Group Recent Developments
Table 84. Symbio Laboratories Corporation Information
Table 85. Symbio Laboratories Description and Major Businesses
Table 86. Symbio Laboratories Product Features and Attributes
Table 87. Symbio Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Symbio Laboratories Recent Developments
Table 89. TUV Nord Corporation Information
Table 90. TUV Nord Description and Major Businesses
Table 91. TUV Nord Product Features and Attributes
Table 92. TUV Nord Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. TUV Nord Recent Developments
Table 94. FoodChain ID Group Corporation Information
Table 95. FoodChain ID Group Description and Major Businesses
Table 96. FoodChain ID Group Product Features and Attributes
Table 97. FoodChain ID Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. FoodChain ID Group Recent Developments
Table 99. AsureQuality Corporation Information
Table 100. AsureQuality Description and Major Businesses
Table 101. AsureQuality Product Features and Attributes
Table 102. AsureQuality Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. AsureQuality Recent Developments
Table 104. Microbac Laboratories Corporation Information
Table 105. Microbac Laboratories Description and Major Businesses
Table 106. Microbac Laboratories Product Features and Attributes
Table 107. Microbac Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Microbac Laboratories Recent Developments
Table 109. Guangdong IQTC Corporation Information
Table 110. Guangdong IQTC Description and Major Businesses
Table 111. Guangdong IQTC Product Features and Attributes
Table 112. Guangdong IQTC Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Guangdong IQTC Recent Developments
Table 114. IFP Institut für Produktqualität GmbH Corporation Information
Table 115. IFP Institut für Produktqualität GmbH Description and Major Businesses
Table 116. IFP Institut für Produktqualität GmbH Product Features and Attributes
Table 117. IFP Institut für Produktqualität GmbH Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. IFP Institut für Produktqualität GmbH Recent Developments
Table 119. Vimta Labs Corporation Information
Table 120. Vimta Labs Description and Major Businesses
Table 121. Vimta Labs Product Features and Attributes
Table 122. Vimta Labs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Vimta Labs Recent Developments
Table 124. Raw Materials Key Suppliers
Table 125. Distributors List
Table 126. Market Trends and Market Evolution
Table 127. Market Drivers and Opportunities
Table 128. Market Challenges, Risks, and Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Pathogen Testing Product Picture
Figure 2. Global Pathogen Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. PCR Product Picture
Figure 4. LAMP Product Picture
Figure 5. Global Pathogen Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Food Industry
Figure 7. Laboratory
Figure 8. Others
Figure 9. Pathogen Testing Report Years Considered
Figure 10. Global Pathogen Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 12. Global Pathogen Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Pathogen Testing Revenue Market Share by Region (2020-2031)
Figure 14. Global Pathogen Testing Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. PCR Revenue Market Share by Player in 2024
Figure 17. LAMP Revenue Market Share by Player in 2024
Figure 18. Global Pathogen Testing Revenue Market Share by Type (2020-2031)
Figure 19. Global Pathogen Testing Revenue Market Share by Application (2020-2031)
Figure 20. North America Pathogen Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Pathogen Testing Revenue (US$ Million) in 2024
Figure 22. North America Pathogen Testing Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Pathogen Testing Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Pathogen Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Pathogen Testing Revenue (US$ Million) in 2024
Figure 29. Europe Pathogen Testing Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Pathogen Testing Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 32. France Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Pathogen Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Pathogen Testing Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Pathogen Testing Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Pathogen Testing Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 44. India Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Pathogen Testing Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Pathogen Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Pathogen Testing Revenue (US$ Million) in 2024
Figure 52. Central and South America Pathogen Testing Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Pathogen Testing Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Pathogen Testing Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Pathogen Testing Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Pathogen Testing Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Pathogen Testing Revenue (US$ Million) in 2024
Figure 58. South America Pathogen Testing Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Pathogen Testing Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Pathogen Testing Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Pathogen Testing Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Pathogen Testing Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Pathogen Testing Revenue (2020-2025) & (US$ Million)
Figure 64. Pathogen Testing Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Pathogen Testing in 2025?
The global market size of Pathogen Testing in 2025 was 6033 Million USD.
What is the annual compound growth rate of the global Pathogen Testing market size from 2025 to 2031?
Which companies rank high in the global Pathogen Testing market?
Which region is expected to have the highest market share?
What was the global market size of Pathogen Testing in 2031?
Related Reports
Global Pathogen Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pathogen Testing market size was US$ 6033 million in 2025 and is forecast to reach a readjusted size of US$ 10130 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 98
USD 4250.00
(Single User License)
Global Pathogen Testing Market Research Report 2026
The global Pathogen Testing market was valued at US$ 6033 million in 2025 and is anticipated to reach US$ 10130 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 111
USD 2900.00
(Single User License)
Pathogen Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pathogen Testing was estimated to be worth US$ 6033 million in 2025 and is projected to reach US$ 10130 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 101
USD 3950.00
(Single User License)
Global Pathogen Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pathogen Testing market size was US$ 5637 million in 2024 and is forecast to a readjusted size of US$ 9467 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 100
USD 4250.00
(Single User License)
Pathogen Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pathogen Testing was estimated to be worth US$ 5637 million in 2024 and is forecast to a readjusted size of US$ 9467 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 114
USD 3950.00
(Single User License)
Global Pathogen Testing Market Research Report 2025
The global market for Pathogen Testing was valued at US$ 5637 million in the year 2024 and is projected to reach a revised size of US$ 9467 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-01-19
Pages: 84
USD 2900.00
(Single User License)
Pathogen Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Pathogen Testing was estimated to be worth US$ 4856.1 million in 2023 and is forecast to a readjusted size of US$ 8265.7 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030
Published Date: 2024-01-18
Pages: 108
USD 3950.00
(Single User License)
Global Pathogen Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pathogen Testing market size was US$ 6033 million in 2025 and is forecast to reach a readjusted size of US$ 10130 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 98
USD 4250.00 (Single User License)Global Pathogen Testing Market Research Report 2026
The global Pathogen Testing market was valued at US$ 6033 million in 2025 and is anticipated to reach US$ 10130 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 111
USD 2900.00 (Single User License)Pathogen Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pathogen Testing was estimated to be worth US$ 6033 million in 2025 and is projected to reach US$ 10130 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-05
Pages: 101
USD 3950.00 (Single User License)Global Pathogen Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pathogen Testing market size was US$ 5637 million in 2024 and is forecast to a readjusted size of US$ 9467 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 100
USD 4250.00 (Single User License)Pathogen Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pathogen Testing was estimated to be worth US$ 5637 million in 2024 and is forecast to a readjusted size of US$ 9467 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 114
USD 3950.00 (Single User License)Global Pathogen Testing Market Research Report 2025
The global market for Pathogen Testing was valued at US$ 5637 million in the year 2024 and is projected to reach a revised size of US$ 9467 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-01-19
Pages: 84
USD 2900.00 (Single User License)Pathogen Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Pathogen Testing was estimated to be worth US$ 4856.1 million in 2023 and is forecast to a readjusted size of US$ 8265.7 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030
Published: 2024-01-18
Pages: 108
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now